Tarjimly (acquired)

Tarjimly addressed a stark gap in real-time translation access for non-English speakers navigating healthcare, legal, and social services. Refugees, immigrants, and low-income communities experienced this problem most acutely—often unable to communicate symptoms to doctors, understand legal rights, or access social benefits due to language barriers. The problem was measurable: hospitals reported higher error rates and longer appointment times for non-English speakers, while many individuals delayed seeking care entirely due to communication fears. Existing alternatives were inadequate. Professional interpreters were expensive and unavailable on-demand, while family members often translated medical information incorrectly. Google Translate lacked contextual accuracy for critical situations. Tarjimly's volunteer-powered platform validated early demand through immediate adoption by healthcare providers and legal aid organizations desperate for accessible solutions. The fact that organizations actively sought out the service—rather than requiring heavy sales efforts—signaled strong product-market fit and confirmed the severity of the underlying problem.

Tarjimly launched with a bare-bones MVP connecting refugee patients needing translation to volunteer interpreters via a simple messaging interface. The founders shipped within weeks rather than months, deliberately omitting features like video calling, professional certification verification, and payment processing—focusing entirely on matching and basic communication. This stripped-down approach meant they could test whether demand actually existed before building infrastructure. The speed paid immediate dividends. Within the first month, refugee clinics in Portland began requesting access, generating organic validation that the problem was real and urgent. Volunteer interpreters signed up faster than anticipated, suggesting strong mission-driven supply. However, this lean execution created friction later: the lack of quality controls initially led to inconsistent translation accuracy, requiring rapid pivots toward vetting processes. Despite these growing pains, the early traction—demonstrated by clinic partnerships and consistent usage—convinced investors the core insight was sound, ultimately positioning Tarjimly for acquisition by CLEAR Global.